Clinical Trials Browser

Phase 2 × Advanced NSCLC With EGFR Mutation × Gefitinib × Clear all

NCT03457337 2020-07-10

S-1 Plus Gefitinib Versus Gefitinib Monotherapy in Patients With EGFR-sensitive Mutation Advanced Non-squamous NSCLC

Phase 2 Unknown

Advanced NSCLC With EGFR Mutation